the investigators aim to set up a multicenter registry study for severe PJP requiring ICU admission. The purpose of this study is 1. to establish a prospective severe PJP registry about clinical characteristics, laboratory and radiographic findings, critical care management and outcomes. 2. to explore the predictive factors associated with outcomes ; 3. to compare the difference between PJP patients with HIV and without HIV infection.
Pneumocystis jiroveci pneumonia (PJP) is a common opportunistic infection in immunocompromised patients. Although the mortality of patients with mild to moderate PJP has declined substantially, the reported outcomes of severe PJP requiring ICU admission, especially with mechanical ventilation are grave. The data on this group of patients is very limited and mainly comes from retrospective studies. the investigators aim to set up a multicenter registry study for patient with severe PJP requiring ICU admission to provide comprehensive descriptive data on diagnosis, clinical course, critical care management and outcomes in a large cohort. All patients with PJP admitted to the participating ICU during a two-year period will be enrolled. The CRF will be made available to the participating sites as a printable paper-based CRF. The following individual patient data for study participants will be collected: * General demographic information * Presence of risk factors for PJP and comorbid condition * use of prophylactic SMZ/TMP, immunosuppressive medications prior to ICU admission * Information about PJP and co-infection diagnosis * vital signs, laboratory(blood serum and BALF sample) and radiologic data at ICU admission and during ICU stay * organ failures and severity of the disease at admission, new onset of organ failures during ICU stay * Medications for PJP, time course and modalities and settings for respiratory support * ICU, 28-day mortality, hospital, 90-day mortality
Study Type
OBSERVATIONAL
Enrollment
300
28-day ICU mortality
28 days mortality after ICU admission
Time frame: Day 28
hospital mortality
mortality at hospital discharge
Time frame: Day 90 (censored at hospital discharge if discharge prior to Day 90)
ICU length of stay
ICU length of stay at ICU discharge
Time frame: Day 90
hospital length of stay
hospital length of stay at hospital discharge
Time frame: Day 90
occurrence of SMZ/TMP treatment failure
SMZ/TMP treatment failure is defined as worsening P/F or radiographic features with a requirement for an increased respiratory support after 7 days of SMZ/TMP treatment (SMZ/TMP)
Time frame: day 7 after SMZ/TMP treatment
mechanical ventilation free days
days without mechanical ventilation during ICU
Time frame: day 28
occurrence of non-invasive mechanical ventilation
Non-invasive mechanical ventilation failure is defined as need for switch from non-invasive mechanical ventilation to invasive mechanical ventilation due to deteriorated respiratory failure
Time frame: day 28
occurrence of pneumothorax or pneumomediastinum
pneumothorax or pneumomediastinum is confirmed by chest X ray or CT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: day 28
ICU acquired infectious disease
incidence of pulmonary of extra-pulmonary infections. Diagnosis of infections disease will be defined by the need of treatment.
Time frame: day 28